Biolingus

• Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus

  Phase 1/2, Recruiting, 15 people, 7 Mar 2022

Sources: clinicaltrials.gov